Could reusing your own blood after bypass cut donor transfusions?
NCT ID NCT06824753
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study looked at whether giving patients their own blood left over in the heart-lung machine after bypass surgery could reduce the need for donor red blood cell transfusions. Sixty adults having elective coronary bypass were split into two groups: one received the leftover blood, the other did not. Researchers tracked how many donor blood units each group needed and checked blood clotting with a special device.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ataturk University
Erzurum, Turkey (Türkiye)
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
autologous blood from the heart-lung machine
What this could lead to
If it works, this could reduce the need for donor blood transfusions after heart bypass surgery, lowering risks and conserving blood supplies.
What could go wrong
This is a small, single-center study with only 60 patients. The results may not apply to all heart surgery patients, and the approach may not significantly change transfusion needs or outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.